AMGN Oct 2023 195.000 put

OPR - OPR Prezzo differito. Valuta in USD.
3,9800
-0,9200 (-18,78%)
Alla chiusura: 03:46PM EDT
Il grafico dei titoli non è supportato dal tuo browser attuale
Chiusura precedente4,9000
Aperto4,1000
Denaro3,7500
Lettera4,3500
Prezzo d'esercizio195,00
Scadenza2023-10-20
Min-Max giorno3,9800 - 4,1000
Contratto - Min-MaxN/D
Volume11
Open Interest75
  • GlobeNewswire

    Amgen and TScan Therapeutics Announce Collaboration to Identify Novel Targets in Crohn’s Disease

    Collaboration Brings Together TScan’s Proprietary Target Discovery Platform and Amgen’s Inflammation Therapeutic Expertise and Research Capabilities TScan to Receive $30 Million Upfront With Potential Development and Commercial Milestone Payments of Over $500 Million THOUSAND OAKS, Calif. and WALTHAM, Mass., May 09, 2023 (GLOBE NEWSWIRE) -- Amgen (NASDAQ:AMGN) and TScan Therapeutics, Inc. (NASDAQ:TCRX), today announced a multi-year collaboration that will use TScan’s proprietary target discovery